Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment
科研动态Nature Genetics
2026-09-28
Poly(ADP-ribose) polymerase inhibitors (PARPi) are commonly used in tumors with homologous recombination deficiency (HRD…
原文：Nature Genetics（本页为平台整理的中文摘要，逐句对照原文核对后发布）